Collaborative for Effective Prescription Opioid Policies (CEPOP) Company Profile

06:07 EDT 23rd June 2018 | BioPortfolio

News Articles [2361 Associated News Articles listed on BioPortfolio]

What are insurance coverage policies for drug treatments for low back pain?

(JAMA Network) An analysis of prescription drug coverage policies for the treatment of low back pain suggests insurers could help to reduce opioid overuse by expanding access to opioid alternatives th...

Length of opioid prescription spell highest risk for misuse after surgery

(Beth Israel Deaconess Medical Center) With opioid overdoses now a leading cause of nonintentional death in the United States, data show most of these deaths can be traced back to an initial prescript...

Using opioid-sparing pain management techniques to better prevent addiction and abuse

Over 2 million people each year switch to persistent opioid use after surgery, and nearly half of all U.S. opioid overdose deaths involve a prescription opioid.

Medicare Changes Opioid, Generic Policies for Part D Plans

CMS proceeds with new policies for Part D pharmacy plans to try to combat opioid addiction while continuing to look into how it can help senior citizens share in savings provided by rebates. Medscap...

Prescription opioids decrease by almost 30%

Prescription opioid volumes declined by 29% from their peak in 2011, according to a report on medicine use in the United States by IQVIA.Prescription opioid volumes peaked in 2011 at the level of 240 ...

Minnesota renews push for tax on prescription opioids

(Reuters) - Citing rising opioid fatalities, Minnesota Governor Mark Dayton on Wednesday announced a renewed legislative proposal to tax prescription opioid pills to help fund treatment.

Scientists developing new vaccines against heroin and prescription opioids

Heroin and prescription opioid abuse and fatal overdoses are a public health emergency in the United States. Vaccines offer a potential new strategy to treat opioid abuse and prevent fatal opioid over...

Opioid Use Assessment Can Reduce Overprescribing

Some hospitals and doctors nationwide are reducing or eliminating opioid prescriptions. For ASCs, opioids still serve an important purpose. However, providers should ask whether an opioid prescription...

Drugs and Medications [828 Associated Drugs and Medications listed on BioPortfolio]

Levorphanol tartrate [Roxane Laboratories, Inc]


Levo-dromoran™ c-ii (levorphanol tartrate) ampuls, vials, tablets potent synthetic opioid for parenteral or oral administration [Valeant Pharmaceuticals International]

LEVO-DROMORAN™ C-II (levorphanol tartrate) AMPULS, VIALS, TABLETS Potent Synthetic Opioid For Parenteral Or Oral Administration

Tramadol hydrochloride [Northstar RxLLC]

Rx Only

Opana [Endo Pharmaceuticals, Inc]

ENDO PHARMACEUTICALS 003466/September 2006 OPANA (Oxymorphone Hydrochloride) INJECTION 1mg/mL CII Opioid Analgesic Rx only

Butrans [Purdue Pharma L.P.]

These highlights do not include all the information needed to use Butrans safely and effectively. See full prescribing information for Butrans. Butrans (buprenorphine) Transdermal System for transderm...

PubMed Articles [1843 Associated PubMed Articles listed on BioPortfolio]

Prescription opioid use among individuals with serious mental illness.

Prevalence and correlates of prescription opioid use were explored in individuals with serious mental illness (SMI) by examining a sample of adults from two inner city community psychiatry clinics. Of...

The FDA's Approach to the Prescription Opioid Problem.

Our nation's ongoing prescription opioid abuse crisis, amounting to over 78 billion dollars in health and social costs annually,is a critical priority for the US Food and Drug Administration (FDA). As...

Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members.

Increases in prescription opioid use in the United States have been attributed to changing prescribing guidelines and attitudes toward pain relief; however, the spread of opioid use within households ...

Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US.

Prescription opioids are among the most effective analgesics to treat moderate to severe pain; however, little is known about the use of prescription opioids in children, particularly those receiving ...

The opioid epidemic and the current prevalence of substance use disorder in anesthesiologists.

There has been a substantial increase in prescription and illicit opioid abuse in the general population observed over the last two decades. Initially fueled by an influx of prescription opioid medica...

Clinical Trials [2631 Associated Clinical Trials listed on BioPortfolio]

Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.

The investigators hypothesize that opioid prescription guided by patient pharmacogenetic profile will diminish opioid-associated undesirable effects by 50% and improve medication complianc...

Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse

Injured trauma patients in the Emergency Department (ED) may be a particularly important group to target for screening and intervention for prescription drug misuse (PDM). These patients h...

Improving Treatment Outcomes for Prescription Opioid Dependence

Overall, this proposal seeks to improve treatment strategies for the significant public health problem of prescription opioid dependence by determining whether gabapentin, a non-narcotic p...

A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire

The purpose of this study is to evaluate the patient usability and reliability of the POMAQ survey to evaluate opioid misuse and abuse among adults with chronic moderate to severe pain, in...

Program for Pain & Prescription Opioid Use in Pregnancy

Pregnant women using prescription opioid medication (pain medications) are invited to take part in a program for the reduction of pain and prescription opioid misuse.

Companies [1651 Associated Companies listed on BioPortfolio]

Collaborative for Effective Prescription Opioid Policies (CEPOP)

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, ...


Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessm...

Lightlake Therapeutics Inc

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. ...

More Information about "Collaborative for Effective Prescription Opioid Policies (CEPOP)" on BioPortfolio

We have published hundreds of Collaborative for Effective Prescription Opioid Policies (CEPOP) news stories on BioPortfolio along with dozens of Collaborative for Effective Prescription Opioid Policies (CEPOP) Clinical Trials and PubMed Articles about Collaborative for Effective Prescription Opioid Policies (CEPOP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Collaborative for Effective Prescription Opioid Policies (CEPOP) Companies in our database. You can also find out about relevant Collaborative for Effective Prescription Opioid Policies (CEPOP) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record